Word

TEVA

Status

Pending

Status Code

688

Status Date

Tuesday, January 9, 2024

Serial Number

98042081

Mark Type

3000

Filing Date

Wednesday, June 14, 2023

Published for Opposition

Tuesday, November 14, 2023

Trademark Owner History

TEVA Pharmaceutical Industries Limited - Owner At Publication

Classifications

5 Human Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, depression, psychological disorders, diabetes and diabetic neuropathy, cardiovascular and blood pressure disorders, irritable bowel syndrome, neurodegenerative diseases and disorders, osteoporosis, pain and neuropathic pain, peripheral nervous system diseases and disorders, digestive tract disorders, gastrointestinal and dermatological diseases and disorders, respiratory system diseases and disorders, sexual dysfunction, symptoms associated with uterine fibroids, urinary incontinence and overactive bladder, AIDS-related disorders, cancer, central nervous system diseases, circulatory system diseases, sensory organ diseases, urogenital organ diseases, peripheral nervous system diseases, bone disorders and bone diseases; Human Pharmaceutical preparations, namely, injectable contraceptives, contraceptive preparations, fertility enhancement preparations, and hormone replacement therapy preparations

The mark consists of a small circle, medium circle, on a swooped angle in the low right corner of a shaded rectangle and above the stylized word TEVA.
Color is not claimed as a feature of the mark.
The English translation of TEVA in the mark is NATURE in Hebrew.

Trademark Events

Jan 9, 2024

Noa E-Mailed - Sou Required From Applicant

Nov 14, 2023

Official Gazette Publication Confirmation E-Mailed

Nov 14, 2023

Published For Opposition

Oct 25, 2023

Notification Of Notice Of Publication E-Mailed

Oct 10, 2023

Approved For Pub - Principal Register

Oct 6, 2023

Teas/Email Correspondence Entered

Oct 6, 2023

Correspondence Received In Law Office

Oct 6, 2023

Teas Response To Office Action Received

Sep 20, 2023

Notification Of Non-Final Action E-Mailed

Sep 20, 2023

Non-Final Action E-Mailed

Sep 20, 2023

Non-Final Action Written

Sep 18, 2023

Assigned To Examiner

Aug 16, 2023

Assigned To Examiner

Jul 19, 2023

Notice Of Design Search Code E-Mailed

Jul 18, 2023

New Application Office Supplied Data Entered

Jun 17, 2023

New Application Entered